Gilead Sciences Underwriting Agreements

10 Contracts & Agreements
Recent Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Underwriting Agreement, dated November 13, 2024, among the Company and Barclays Capital Inc. and BofA Securities, Inc., as representatives of the several underwriters listed in...
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2024
Underwriting Agreement, dated September 7, 2023, among the Company and Barclays Capital Inc. and Citigroup Global Markets Inc., as representatives of the several underwriters...
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2023
Underwriting Agreement, dated September 23, 2020, among the Company and Barclays Capital Inc. and Wells Fargo Securities, LLC, as representatives of the several underwriters...
Underwriting Agreements
Gilead Sciences
Biotechnology
DE
2020
Underwriting Agreement, dated September 14, 2017, among the Company and Merrill Lynch, Pierce, Fenner & Smith Incorporated and Wells Fargo Securities, LLC, as representatives of...
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2017
GILEAD SCIENCES, INC. $500,000,000 1.950% SENIOR NOTES DUE 2022 $750,000,000 2.500% SENIOR NOTES DUE 2023 $1,250,000,000 2.950% SENIOR NOTES DUE 2027 $750,000,000 4.000% SENIOR...
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2016
GILEAD SCIENCES, INC. $1,000,000,000 1.850% SENIOR NOTES DUE 2018 $2,000,000,000 2.550% SENIOR NOTES DUE 2020 $1,000,000,000 3.250% SENIOR NOTES DUE 2022 $2,750,000,000 3.650%...
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2015
GILEAD SCIENCES, INC. $500,000,000 2.350% SENIOR NOTES DUE 2020 $1,750,000,000 3.500% SENIOR NOTES DUE 2025 $1,750,000,000 4.500% SENIOR NOTES DUE 2045 Underwriting Agreement
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2014
GILEAD SCIENCES, INC. $500,000,000 2.050% SENIOR NOTES DUE 2019 $1,750,000,000 3.700% SENIOR NOTES DUE 2024 $1,750,000,000 4.800% SENIOR NOTES DUE 2044 Underwriting Agreement
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2014
GILEAD SCIENCES, INC. $750,000,000 2.40% SENIOR NOTES DUE 2014 $700,000,000 3.05% SENIOR NOTES DUE 2016 $1,250,000,000 4.40% SENIOR NOTES DUE2021 $1,000,000,000 5.65% SENIOR NOTES...
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2011
GILEAD SCIENCES, INC. 4.50% SENIOR NOTES DUE 2021 ($1,000,000,000 Aggregate Principal Amount) Underwriting Agreement
Underwriting Agreements
Gilead Sciences
Biotechnology
NY
2011